Table 4.
Incremental cost-effectiveness ratio after one-way deterministic sensitivity analysis on selected parameters
| ICER: ECT v. rTMS | ICER: rTMS + ECT v. ECT | |||
|---|---|---|---|---|
| Parameter | 50% lower | 50% higher | 50% lower | 50% higher |
| Continuation Tx | ||||
| In-hospital days ECT | ECT dominates | €1699 | €72 881 | €72 455 |
| In-hospital days rTMS | €5737 | ECT dominates | €65 149 | €80 186 |
| Psychiatrist visits ECT | ECT dominates | ECT dominates | €72 671 | €72 665 |
| Psychiatrist visits rTMS | ECT dominates | ECT dominates | €72 306 | €73 030 |
| A&E visits ECT | ECT dominates | ECT dominates | €72 672 | €72 664 |
| A&E visits rTMS | ECT dominates | ECT dominates | €72 603 | €72 733 |
| GP visits ECT | ECT dominates | ECT dominates | €72 695 | €72 641 |
| GP visits rTMS | ECT dominates | ECT dominates | €71 653 | €73 683 |
| Acute Tx | ||||
| ECT treatment costs | ECT dominates | €39 132 | €73 599 | €71 737 |
| rTMS treatment costs | €41 969 | ECT dominates | €39 202 | €106 134 |
ICER, incremental cost-effectiveness ratio; ECT, Electroconvulsive therapy; rTMS, repetitive transcranial magnetic stimulation; Tx, treatment; A&E, accident and emergency; GP, general practitioner.